
Genelux Corp
GNLXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$3.08
Day High
$3.09
Day Low
$3.02
Prev. Close
$3.07
VolumeShares traded today.
110.25K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$136.76M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-3.58
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$8.54
52W LowLowest price over the past 52 weeks.
$2.29
50D MAAverage closing price over the last 50 trading days.
$2.72
200D MAAverage closing price over the last 200 trading days.
$3.77
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+4.5%1M
+22.0%6M
-42.3%YTD
-33.0%1Y
+26.0%About
Genelux Corporation is a publicly traded late clinical-stage company developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus (VACV), a stable DNA virus with a large engineering capacity.
genelux.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade GNLX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.